(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.08%) $82.56
(1.33%) $2.06
(-0.49%) $2 346.20
(-0.92%) $27.41
(0.03%) $961.80
(0.11%) $0.933
(0.20%) $11.00
(0.07%) $0.797
(0.01%) $93.31
0.00% $ 18.00
Live Chart Being Loaded With Signals
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others...
Stats | |
---|---|
Tagesvolumen | 465.00 |
Durchschnittsvolumen | 493 725 |
Marktkapitalisierung | 0.00 |
Last Dividend | $0.108 ( 2022-03-30 ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.819 (4.55%) |
Volumen Korrelation
Olympus Corporation Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Olympus Corporation Korrelation - Währung/Rohstoff
Olympus Corporation Finanzdaten
Annual | 2022 |
Umsatz: | $868.87B |
Bruttogewinn: | $571.70B (65.80 %) |
EPS: | $90.35 |
FY | 2022 |
Umsatz: | $868.87B |
Bruttogewinn: | $571.70B (65.80 %) |
EPS: | $90.35 |
FY | 2021 |
Umsatz: | $730.54B |
Bruttogewinn: | $459.53B (62.90 %) |
EPS: | $10.05 |
FY | 2020 |
Umsatz: | $797.41B |
Bruttogewinn: | $499.57B (62.65 %) |
EPS: | $39.37 |
Financial Reports:
No articles found.
Olympus Corporation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.0156 | 2003-03-26 |
Last Dividend | $0.108 | 2022-03-30 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 25 | -- |
Total Paid Out | $1.329 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.62 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.84 | |
Div. Directional Score | 7.24 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SCGLY | Ex Dividend Junior | 2023-05-25 | Annually | 0 | 0.00% | |
FSUGY | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
AGESY | Ex Dividend Junior | 2023-10-25 | Annually | 0 | 0.00% | |
YATRF | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
MONDY | Ex Dividend Knight | 2023-08-24 | Semi-Annually | 0 | 0.00% | |
CNLTP | Ex Dividend Knight | 2023-07-07 | Quarterly | 0 | 0.00% | |
STBI | Ex Dividend Knight | 2023-08-14 | Quarterly | 0 | 0.00% | |
HKXCY | Ex Dividend Knight | 2023-08-28 | Semi-Annually | 0 | 0.00% | |
ASBFY | Ex Dividend Knight | 2023-06-01 | Annually | 0 | 0.00% | |
OLCLF | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.173 | 1.500 | 6.54 | 9.81 | [0 - 0.5] |
returnOnAssetsTTM | 0.0558 | 1.200 | 8.14 | 9.77 | [0 - 0.3] |
returnOnEquityTTM | 0.125 | 1.500 | 9.73 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.03 | 0.800 | 4.83 | 3.86 | [1 - 3] |
quickRatioTTM | 0.544 | 0.800 | -1.503 | -1.203 | [0.8 - 2.5] |
cashRatioTTM | 0.495 | 1.500 | 8.36 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.253 | -1.500 | 5.78 | -8.67 | [0 - 0.6] |
interestCoverageTTM | 35.39 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 64.44 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 34.81 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.584 | -1.500 | 7.67 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.686 | 1.000 | 1.908 | 1.908 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.236 | 1.000 | 7.28 | 7.28 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.232 | 1.000 | 9.82 | 9.82 | [0.2 - 2] |
assetTurnoverTTM | 0.323 | 0.800 | -1.183 | -0.946 | [0.5 - 2] |
Total Score | 10.65 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 46.41 | 1.000 | 5.41 | 0 | [1 - 100] |
returnOnEquityTTM | 0.125 | 2.50 | 9.82 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 34.81 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 64.44 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.000360 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.182 | 1.000 | 7.95 | 0 | [0.1 - 0.5] |
Total Score | 3.84 |
Olympus Corporation
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.